Proteome Sciences (LON:PRM) Trading 4.7% Higher – Time to Buy?

Proteome Sciences plc (LON:PRM)’s stock price traded up 4.7% on Friday . The company traded as high as GBX 4.98 ($0.06) and last traded at GBX 4.70 ($0.06). 192,580 shares traded hands during mid-day trading, an increase of 10% from the average session volume of 175,323 shares. The stock had previously closed at GBX 4.49 ($0.06).

Proteome Sciences Price Performance

The stock has a market cap of £14.37 million, a price-to-earnings ratio of -3.52 and a beta of 0.07. The company has a quick ratio of 0.37, a current ratio of 0.20 and a debt-to-equity ratio of -258.66. The stock’s 50 day moving average price is GBX 3.89 and its two-hundred day moving average price is GBX 3.27.

Proteome Sciences Company Profile

Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant, provides an analysis of protein activity across regulatory and signaling pathways; and TMTcalibrator, analyzes where diseased or treated tissue can be analyzed in parallel with peripheral fluids.